Yuyu Pharma Beheer
Beheer criteriumcontroles 0/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Robert Yu
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 4.6yrs |
Eigendom CEO | 26.6% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
Unpleasant Surprises Could Be In Store For Yuyu Pharma, Inc.'s (KRX:000220) Shares
Nov 13Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance
Aug 24Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now
Aug 07Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden
Apr 02Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?
Mar 08The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More
Feb 10We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide
Jan 07Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly
Dec 20Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?
Dec 03CEO
Robert Yu
4.6yrs
Tenure
Mr. Wonsang Yu, also known as Robert, has been President and Chief Executive Officer of Yuyu Pharma, Inc. since April 6, 2020 and served as its Vice President. Prior to joining Yuyu Pharma in 2008, Mr. Yu...